Michael Marash, CEO of P-Cure, stated, “The integration of Proton ARC therapy into routine clinical practice underscores the versatility and innovation of P-Cure’s proton therapy system. By addressing the challenges of space, cost, and accessibility, we are democratizing proton therapy and bringing this life-saving technology to more patients worldwide. This collaboration with Hadassah exemplifies how advanced technology can align with clinical excellence to transform cancer care.”
About P-Cure
Ad Statistics
Times Displayed: 19162
Times Visited: 365 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
P-Cure is a leading provider of compact and innovative proton therapy solutions designed to enhance accessibility and precision in cancer treatment. With its groundbreaking technologies, P-Cure addresses the limitations of conventional systems, offering compact designs that fit into existing clinical settings without compromising treatment efficacy.
Proton therapy, including for proton active scanning therapy – the basis for ARC treatment -- is FDA-cleared for certain tumor localizations. Consult your healthcare provider for details about your specific treatment needs.
Back to HCB News
